| Due Diligence for Asset Managers |
|---|
|
Analyze the public filings of asset managers Dive into the EDGAR, IAPD, CAFR source data |
|
⚲
|
| Keyboard |
| VTV Therapeutics Inc | |
|---|---|
| Ticker | VTVT |
| CIK # | 0001641489 |
| CUSIP | 918385204 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 4170 Mendenhall Oaks Pkwy, High Point, NC 27265 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| VTV Therapeutics Inc | 2024-03-07 | 51.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001641489] | 10-K | |
| [0001641489] | 10-Q | |
| [0001641489] | 3 | |
| [0001641489] | 4 | |
| [0001641489] | 8-K | |
| [0001641489] | D | |
| [0001641489] | SC 13D | |
| [0001641489] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Millennium Management LLC | VTV Therapeutics Inc | [2026-03-27] | 0.0 |
| FMR LLC | VTV Therapeutics Inc | [2024-11-12] | 0.0 |
| Samsara Biocapital LP | VTV Therapeutics Inc | [2024-03-05] | 10.4 |
| Baker Bros Advisors LP | VTV Therapeutics Inc | [2024-03-05] | 4.99 |
| Medpace Investors LLC | VTV Therapeutics Inc | [2022-08-23] | 5.16 |
| G42 Investments AI Holdings RSC Ltd | VTV Therapeutics Inc | [2022-06-10] | 13.4 |
| Piper Jaffray Companies | VTV Therapeutics Inc | [2016-02-11] | 7.5 |
| Franklin Resources Inc | VTV Therapeutics Inc | [2015-09-10] | 12.2 |
| MacAndrews & Forbes Inc | VTV Therapeutics Inc | [2015-08-14] | 81.7 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Sekhri Paul J
Class A Common Stock · derivative
|
2026-02-17 | Grant | 140,000 | $36.92 | 5,168,800 |
|
Tung Michael Stephen
Employee stock option (right to buy) · derivative
|
2026-02-17 | Grant | 44,969 | $36.92 | 1,660,255 |
|
Class A Common Stock
|
2025-09-22 | Grant | 106,000 | $15.27 | 1,618,620 |
|
Pre-Funded Warrants (Right to Buy) · derivative
|
2025-09-22 | Grant | 877,214 | ||
|
Warrant (Right to Buy) · derivative
|
2025-09-22 | Grant | 983,214 | ||
|
Common Warrant · derivative
|
2025-09-03 | Grant | 2,400,605 | ||
|
Common Warrant · derivative
|
2025-09-03 | Grant | 221,452 | ||
|
Prefunded Warrants · derivative
|
2025-09-03 | Grant | 2,353,913 | ||
|
Prefunded Warrants · derivative
|
2025-09-03 | Grant | 217,144 | ||
|
Common Stock
|
2025-09-03 | Grant | 46,692 | ||
|
Common Stock
|
2025-09-03 | Grant | 4,308 | ||
|
Pre-Funded Warrants (Right to Buy) · derivative
|
2025-09-03 | Grant | 655,523 | ||
|
Warrant to Purchase Class A Common Stock (Right to Buy) · derivative
|
2025-09-03 | Grant | 655,523 | ||
|
Baker Brothers Life Sciences LP +5
Non- Qualified Stock Option (right to buy) · derivative
|
2025-06-10 | Grant | 4,000 | $0.00 | |
|
Baker Brothers Life Sciences LP +5
Non- Qualified Stock Option (right to buy) · derivative
|
2025-06-10 | Grant | 4,000 | $0.00 | |
|
Spiegelman Daniel K
Director stock option (right to buy) · derivative
|
2025-06-10 | Grant | 4,000 | $16.59 | 66,360 |
|
Akkaraju Srinivas
Director stock option (right to buy) · derivative
|
2025-06-10 | Grant | 4,000 | $16.59 | 66,360 |
|
Phillips Anne M
Director stock option (right to buy) · derivative
|
2025-06-10 | Grant | 4,000 | $16.59 | 66,360 |
|
Al-Marzooqi Fahed
Director stock option (right to buy) · derivative
|
2025-06-10 | Grant | 4,000 | $16.59 | 66,360 |
|
Tung Michael Stephen
Employee stock option (right to buy) · derivative
|
2025-05-19 | Grant | 45,000 | $21.25 | 956,250 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 35 | 1,487,276 |
| 2025-12-31 | 27 | 1,283,622 |
| 2025-09-30 | 23 | 988,279 |
| 2025-06-30 | 22 | 587,123 |
| 2025-03-31 | 22 | 571,719 |
| 2024-12-31 | 18 | 551,416 |
| 2024-09-30 | 21 | 542,324 |
| 2024-06-30 | 20 | 348,142 |
| 2024-03-31 | 20 | 335,332 |
| 2023-12-31 | 15 | 69,491 |
| 2023-09-30 | 26 | 3,444,994 |
| 2023-06-30 | 21 | 3,516,048 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 283 |
| Activest Wealth Management | [2026-06-30] | SOLE | 0 | 50 |
| Corecap Advisors LLC | [2026-06-30] | SOLE | 0 | 45 | Prev | Page 1 | Next |